Revolution Medicines to Participate in Upcoming Investor Conferences
05. November 2024 09:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Nanomedicine Market Valuation to Reach USD 358 Billion by 2032 | Amid Rising Demand for Advanced Medical Solutions and Precision Healthcare
12. Dezember 2023 10:06 ET
|
Market.Us
New York, Dec. 12, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global nanomedicine market reached a value of USD 153 billion in 2023 and is projected to witness substantial growth,...
[Latest] Global 6G Market Size/Share Worth USD 40.5 Billion by 2032 at a 35.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
07. Dezember 2023 14:30 ET
|
Custom Market Insights
Austin, TX, USA, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “6G Market Size, Trends and Insights By Technology (Terahertz Communication,...
Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference
09. Juni 2022 16:02 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., June 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Real Estate Entrepreneur Robbie Antonio Announces New Spec Home Developments Planned for Connecticut Markets
11. April 2022 16:01 ET
|
Businessman Robbie Antonio
New York, New York, April 11, 2022 (GLOBE NEWSWIRE) -- International real estate developer Robbie Antonio has announced his upcoming plans to begin a series of spec home development projects...
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER
04. April 2019 12:31 ET
|
NANOBIOTIX
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe...
Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval
04. April 2019 12:31 ET
|
NANOBIOTIX
NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union...
The Rainmaker Group Ranked on Inc. 500|5000 List of Fastest-Growing Private Companies in America
02. September 2011 09:47 ET
|
Rainmaker Group
Atlanta, GA, Sept. 2, 2011 (GLOBE NEWSWIRE) -- Inc. magazine ranked The Rainmaker Group No. 2907 on its annual Inc. 500|5000 list, an exclusive ranking of the nation's fastest-growing private...